Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Health and Human Services Department, Health Insurance and Managed Care, Medicare, Novo Nordisk A/S, Obesity, Ozempic (Drug), Prices (Fares, Fees and Rates), United States Politics and Government
←Social Media Users Shut Down GOP Senator Over His Out-Of-Control Disasters Claim
Seth Meyers Wants Biden To Do 1 ‘Wicked’ Thing At Donald Trump’s Inauguration→

More posts

  • We’re pediatricians who vaccinated our children and grandchildren. Trust us over Trump.

  • Ocasio-Cortez surpasses Newsom as 2028 Dem presidential favorite on Polymarket

  • Rubio, Bessent stayed behind as Trump secretly switched planes over alleged Iran threat

  • Students wait for A-level, T-level and BTec results

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube